84 related articles for article (PubMed ID: 1434816)
1. Pathology and immunology of acute leukemia.
Mirro J
Leukemia; 1992 Nov; 6 Suppl 4():13-5. PubMed ID: 1434816
[TBL] [Abstract][Full Text] [Related]
2. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain.
Chillón CM; García-Sanz R; Balanzategui A; Ramos F; Fernández-Calvo J; Rodríguez MJ; Rodríguez-Salazar MI; Corrales A; Calmuntia MJ; Orfão A; González M; San Miguel JF
Haematologica; 2001 Feb; 86(2):162-6. PubMed ID: 11224485
[TBL] [Abstract][Full Text] [Related]
4. Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology.
Saikevych IA; Kerrigan DP; McConnell TS; Head DR; Appelbaum FR; Willman CL
Leukemia; 1991 May; 5(5):373-82. PubMed ID: 2033959
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and biological implications of acute mixed lineage (hybrid) leukemias.
Altman AJ
Am J Pediatr Hematol Oncol; 1990; 12(2):123-33. PubMed ID: 2198821
[TBL] [Abstract][Full Text] [Related]
6. Secondary chromosomal abnormalities in acute leukemias.
Johansson B; Mertens F; Mitelman F
Leukemia; 1994 Jun; 8(6):953-62. PubMed ID: 8207990
[TBL] [Abstract][Full Text] [Related]
7. Biological and clinical significance of cytogenetic study on 100 acute lymphoblastic leukemia and 219 acute non-lymphoblastic leukemia.
Ye J; Cao Q; Su X; Huang Q; Ma Z; Wang Z; Huang W; Chen Z; Chen S
Chin Med J (Engl); 1997 Feb; 110(2):90-5. PubMed ID: 9594276
[TBL] [Abstract][Full Text] [Related]
8. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics.
Childs CC; Hirsch-Ginsberg C; Walters RS; Andersson BS; Reuben J; Trujillo JM; Cork A; Stass SA; Freireich EJ; Zipf TF
Leukemia; 1989 Nov; 3(11):777-83. PubMed ID: 2811478
[TBL] [Abstract][Full Text] [Related]
9. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction.
van Dongen JJ; Breit TM; Adriaansen HJ; Beishuizen A; Hooijkaas H
Leukemia; 1992; 6 Suppl 1():47-59. PubMed ID: 1548936
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo.
Martinez-Climent JA; Lane NJ; Rubin CM; Morgan E; Johnstone HS; Mick R; Murphy SB; Vardiman JW; Larson RA; Le Beau MM
Leukemia; 1995 Jan; 9(1):95-101. PubMed ID: 7845034
[TBL] [Abstract][Full Text] [Related]
11. Specific chromosomal aberrations in de novo acute myeloid leukemia: a comparative analysis of results with a report of three novel chromosomal rearrangements t(7;14)(q35;q13), t(8;18)(p11.2;q12), t(13;15) in Indian population.
Ahmad F; Dalvi R; Das BR; Mandava S
Cancer Detect Prev; 2008; 32(2):168-77. PubMed ID: 18639991
[TBL] [Abstract][Full Text] [Related]
12. New insights into the biology of acute myeloid leukemia and their impact on treatment.
Hiddemann W; Haferlach T; Schoch C; Behre G; Kohlmann A; Kern W; Feuring-Buske M; Bohlander S
Verh Dtsch Ges Pathol; 2003; 87():72-8. PubMed ID: 16888897
[TBL] [Abstract][Full Text] [Related]
13. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
14. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
15. Lineage commitment in biphenotypic acute leukemia.
Buccheri V; Matutes E; Dyer MJ; Catovsky D
Leukemia; 1993 Jun; 7(6):919-27. PubMed ID: 8501986
[TBL] [Abstract][Full Text] [Related]
16. The classification of acute leukaemia.
Catovsky D; Matutes E
Leukemia; 1992; 6 Suppl 2():1-6. PubMed ID: 1578905
[TBL] [Abstract][Full Text] [Related]
17. [Phenotypic and genotypic analysis of acute leukemia--current status of lineage specific classification].
Kawa K; Hara J
Nihon Rinsho; 1992 Jun; 50(6):1315-20. PubMed ID: 1518151
[TBL] [Abstract][Full Text] [Related]
18. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and classification of the acute leukemias: recent advances and controversial issues.
Taylor CG; Stasi R; Bastianelli C; Venditti A; Del Poeta G; Amadori S; Sargent J
Hematopathol Mol Hematol; 1996; 10(1-2):1-38. PubMed ID: 8792146
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]